Format

Send to:

Choose Destination
See comment in PubMed Commons below
Heart. 2009 Nov;95(22):1851-6. doi: 10.1136/hrt.2008.156034. Epub 2009 Jul 8.

Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK.

Author information

  • 1Imperial College, London, UK.

Abstract

OBJECTIVE:

To investigate the secular trend in survival after a new diagnosis of heart failure in the UK population.

DESIGN AND SETTING:

Comparison of all-cause mortality in the 6 months after diagnosis of heart failure in population-based studies in the south east of England in 2004-5 (Hillingdon-Hastings Study) and 1995-7 (Hillingdon-Bromley Studies).

PARTICIPANTS:

396 patients in the 2004-5 cohort and 552 patients in the 1995-7 cohort with incident (new) heart failure.

MAIN OUTCOME MEASURES:

All-cause mortality.

RESULTS:

All-cause mortality rates were 6% (95% CI 3% to 8%) at 1 month, 11% (8% to 14%) at 3 months and 14% (11% to 18%) at 6 months in the 2004-5 cohort compared with 16% (13% to 20%), 22% (19% to 25%) and 26% (22% to 29%), respectively, in the 1995-7 cohort (difference between the two cohorts, p<0.001). The difference in survival was not explained by any difference in the demographics or severity of heart failure at presentation. There was a difference at baseline and thereafter in the use of neurohormonal antagonists (beta-blockers and angiotensin-converting enzyme inhibitors).

CONCLUSIONS:

Although early mortality remains high among patients with newly diagnosed heart failure in the UK general population, there is strong evidence of a marked improvement in survival from 1995-7 to 2004-5, perhaps partly explained by an increased usage of neurohormonal antagonists.

PMID:
19587390
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk